亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

Clopidogrel

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 陜西西安市付款后3天內(nèi)
庫(kù)存 1000KG起訂10KG
品牌 DSTECH
型號(hào) 113665-84-2
規(guī)格 Enterprise standard
過期 長(zhǎng)期有效
更新 2011-06-07 16:18
 

Shaanxi Dasheng Chemical Tech Co., Ltd.

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明
                                        Clopidogrel


1. Chemical Name: Methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
2. CAS RN: 113665-84-2
3. Structural Formula:
4. Molecular Formula & Molecular Weight: C16H16ClNO2S  321.82
5. Characters: It’s a white powder.
6. Quality Standard: Enterprise standard.
7. Usage: It’s a new-type antiplatalet therapy, used for cure acute thrombogenicity cardiovascular and cerebrovascular diseases invasive surgery operation.
8. Storage: It should be kept in cool and dry place, stored in sealed containers.
9. Packing: paper bucket,25 kg/package.
10. Shelf life: 2 years.
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
N-Acetylglycine acid DL-N-Acetaminocinnamic Acid Intermediate of Bicalutamide Chlorhexidine Acetate Chlorhexidine Hydrochloride Intermediate of Bicalutamide Intermediate of Bicalutamide
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |